All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
KARACHI, Pakistan – Hit by international sanctions, medical device manufacturers in Iran now are looking to get their products out to the world with a little help from neighbor and friend Pakistan. This year, Iran’s med-tech makers have taken their first steps toward finding a new route for their products that goes beyond its neighbors.
Telemedicine and robotic medicine have reshaped the provision of health care services during one of the largest annual gatherings in the world – health care that the government of Saudi Arabia provides free of charge to all pilgrims. The logistics associated with the spike in demand for health care can be daunting, but advances in medical technology have made this challenge easier.
RIYADH, Saudi Arabia – Saudi Arabia, a country best known as one of the world's largest oil producers, is looking to develop a stronger domestic biotech and pharmaceutical industry, partly to diversify its economy and partly to address its domestic health care needs.
RIYADH, Saudi Arabia – Saudi Arabia, a country best known as one of the largest oil producers in the world, is looking to develop a stronger domestic biotech and pharmaceutical industry, partly to diversify its economy and partly to address its domestic health care needs.
KARACHI, Pakistan – Pakistan is running short of women doctors. That's not due to a lack of medical education facilities – 70% of all medical students are women – but because many of them leave midway through their careers. The Muslim-majority country now is looking to new medical technologies and telemedicine to address this issue. One startup that launched in 2017, Sehat Kahani, is relying on telemedicine to expand the reach of health care by, in large part, tapping into this pool of medical talent.
KARACHI, Pakistan – Issues surrounding drug pricing and government policies are challenges for not only Pakistan's domestic pharmaceutical companies, but also multinational corporations, providing further evidence the current pricing debate is not just a Western problem.
KARACHI, Pakistan – Issues surrounding drug pricing and government policies are challenges for not only Pakistan's domestic pharmaceutical companies, but also multinational corporations, providing further evidence the current pricing debate is not just a Western problem.
KARACHI, Pakistan – Without any domestic production capacity and facing virtually chronic shortages of vaccines on the market, Pakistan is now partnering with China to build capacity and working to create a policy environment more conducive to facilitating production.
BEIJING – China will kickstart a phase III trial Feb. 3 to determine whether patients with 2019-nCoV can be treated with Gilead Sciences Inc.’s NUC inhibitor,...
HONG KONG – In another example that communication is proving as difficult as containment in the current coronavirus outbreak, China’s state media reported, to...
SEATTLE – Tracing the family tree of COVID-19 through its evolving DNA sequence makes it possible to disprove many false claims circulating on social media about...
HONG KONG – A team of researchers at Hong Kong University of Science and Technology (HKUST) claim to have invented the world’s fastest portable 2019-nCoV...
New analysis from Clarivate Analytics' Cortellis Forecast Team predicts 11 medicines set to enter the market in 2020 will reach more than $1 billion in sales by...
BioWorld Premium
Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.
